Jan van Amsterdam , Ton Nabben , Wim van den Brink
{"title":"2-MMC和3-MMC在荷兰非法药物市场上的出现:对其流行程度和风险的系统叙述审查","authors":"Jan van Amsterdam , Ton Nabben , Wim van den Brink","doi":"10.1016/j.drugpo.2025.104971","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and Aims</h3><div>Use of the synthetic methylmethcathinones 2-MMC and 3-MMC (2/3-MMC) is emerging, especially among young people, but their health risks remain unclear.</div></div><div><h3>Method</h3><div>A systematic narrative review was conducted on studies describing the availability, pharmaco-toxicological profile, and user characteristics of 2/3-MMC, with a focus on the situation in The Netherlands.</div></div><div><h3>Results</h3><div>Among nightlife youth (16–35 yrs.) in The Netherlands, reported past-year 3-MMC use increased almost four-fold within two years,and in 2022 became the third most commonly used substance (33.7 %), after cannabis and MDMA. 2/3-MMC appears to have a pharmaco-toxicological profile similar to 4-MMC (mephedrone), with similar dopaminergic but less serotonergic activity. Their shorter duration of action may lead to increased craving and more frequent re-dosing compared to 4-MMC. Low price, high availability and positive recommendations on social media have attracted (very) young (aged 14–17), who are often particularly vulnerable. Despite a legal ban on 3-MMC in 2021, the number of individuals seeking treatment for problematic 3-MMC use in the Netherlands rose from 33 in 2021 to 330 in 2023. Most cases involved polydrug users.</div></div><div><h3>Conclusions</h3><div>In general, 2/3-MMC appear to be less toxic and harmful than other illicit substances though their use may result in more craving, more frequent re-dosing and, thus, to more dependence than 4-MMC. The number of treatment seeking problematic 3-MMC users is increasing. Drug regulation may help prevent a further rise in 2/3-MMC use, although a shift to other cathinones cannot be ruled out. Mental health organisations should therefore remain vigilant to monitor problematic 2/3-MMC use, especially among vulnerable (very) young users.</div></div>","PeriodicalId":48364,"journal":{"name":"International Journal of Drug Policy","volume":"145 ","pages":"Article 104971"},"PeriodicalIF":4.4000,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Appearance of 2-MMC and 3-MMC on the illicit drug market in the Netherlands: A systematic narrative review of the prevalence and risks\",\"authors\":\"Jan van Amsterdam , Ton Nabben , Wim van den Brink\",\"doi\":\"10.1016/j.drugpo.2025.104971\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background and Aims</h3><div>Use of the synthetic methylmethcathinones 2-MMC and 3-MMC (2/3-MMC) is emerging, especially among young people, but their health risks remain unclear.</div></div><div><h3>Method</h3><div>A systematic narrative review was conducted on studies describing the availability, pharmaco-toxicological profile, and user characteristics of 2/3-MMC, with a focus on the situation in The Netherlands.</div></div><div><h3>Results</h3><div>Among nightlife youth (16–35 yrs.) in The Netherlands, reported past-year 3-MMC use increased almost four-fold within two years,and in 2022 became the third most commonly used substance (33.7 %), after cannabis and MDMA. 2/3-MMC appears to have a pharmaco-toxicological profile similar to 4-MMC (mephedrone), with similar dopaminergic but less serotonergic activity. Their shorter duration of action may lead to increased craving and more frequent re-dosing compared to 4-MMC. Low price, high availability and positive recommendations on social media have attracted (very) young (aged 14–17), who are often particularly vulnerable. Despite a legal ban on 3-MMC in 2021, the number of individuals seeking treatment for problematic 3-MMC use in the Netherlands rose from 33 in 2021 to 330 in 2023. Most cases involved polydrug users.</div></div><div><h3>Conclusions</h3><div>In general, 2/3-MMC appear to be less toxic and harmful than other illicit substances though their use may result in more craving, more frequent re-dosing and, thus, to more dependence than 4-MMC. The number of treatment seeking problematic 3-MMC users is increasing. Drug regulation may help prevent a further rise in 2/3-MMC use, although a shift to other cathinones cannot be ruled out. Mental health organisations should therefore remain vigilant to monitor problematic 2/3-MMC use, especially among vulnerable (very) young users.</div></div>\",\"PeriodicalId\":48364,\"journal\":{\"name\":\"International Journal of Drug Policy\",\"volume\":\"145 \",\"pages\":\"Article 104971\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-08-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Drug Policy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0955395925002671\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SUBSTANCE ABUSE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Drug Policy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0955395925002671","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
Appearance of 2-MMC and 3-MMC on the illicit drug market in the Netherlands: A systematic narrative review of the prevalence and risks
Background and Aims
Use of the synthetic methylmethcathinones 2-MMC and 3-MMC (2/3-MMC) is emerging, especially among young people, but their health risks remain unclear.
Method
A systematic narrative review was conducted on studies describing the availability, pharmaco-toxicological profile, and user characteristics of 2/3-MMC, with a focus on the situation in The Netherlands.
Results
Among nightlife youth (16–35 yrs.) in The Netherlands, reported past-year 3-MMC use increased almost four-fold within two years,and in 2022 became the third most commonly used substance (33.7 %), after cannabis and MDMA. 2/3-MMC appears to have a pharmaco-toxicological profile similar to 4-MMC (mephedrone), with similar dopaminergic but less serotonergic activity. Their shorter duration of action may lead to increased craving and more frequent re-dosing compared to 4-MMC. Low price, high availability and positive recommendations on social media have attracted (very) young (aged 14–17), who are often particularly vulnerable. Despite a legal ban on 3-MMC in 2021, the number of individuals seeking treatment for problematic 3-MMC use in the Netherlands rose from 33 in 2021 to 330 in 2023. Most cases involved polydrug users.
Conclusions
In general, 2/3-MMC appear to be less toxic and harmful than other illicit substances though their use may result in more craving, more frequent re-dosing and, thus, to more dependence than 4-MMC. The number of treatment seeking problematic 3-MMC users is increasing. Drug regulation may help prevent a further rise in 2/3-MMC use, although a shift to other cathinones cannot be ruled out. Mental health organisations should therefore remain vigilant to monitor problematic 2/3-MMC use, especially among vulnerable (very) young users.
期刊介绍:
The International Journal of Drug Policy provides a forum for the dissemination of current research, reviews, debate, and critical analysis on drug use and drug policy in a global context. It seeks to publish material on the social, political, legal, and health contexts of psychoactive substance use, both licit and illicit. The journal is particularly concerned to explore the effects of drug policy and practice on drug-using behaviour and its health and social consequences. It is the policy of the journal to represent a wide range of material on drug-related matters from around the world.